Contineum Therapeutics (NASDAQ:CTNM) Coverage Initiated at Jones Trading
Equities researchers at Jones Trading began coverage on shares of Contineum Therapeutics (NASDAQ:CTNM – Get Free Report) in a research report issued on Thursday,Benzinga reports. The brokerage set a “buy” rating and a $23.00 price target on the stock. Jones Trading’s price objective suggests a potential upside of 244.83% from the company’s current price. CTNM […]
Equities researchers at Jones Trading began coverage on shares of Contineum Therapeutics (NASDAQ:CTNM – Get Free Report) in a research report issued on Thursday,Benzinga reports. The brokerage set a “buy” rating and a $23.00 price target on the stock. Jones Trading’s price objective suggests a potential upside of 244.83% from the company’s current price. CTNM […]
